Basic information Safety Supplier Related

cypate

Basic information Safety Supplier Related

cypate Basic information

Product Name:
cypate
Synonyms:
  • cypate
  • 3-(2-((1E,3E,5E,7Z)-7-(3-(2-carboxyethyl)-1,1-dimethyl-1,3-dihydro-2H-benzo[e]indol-2-ylidene)hepta-1,3,5-trien-1-yl)-1,1-dimethyl-1H-benzo[e]indol-3-ium-3-yl)propanoate
  • 3-(2-(7-(3-(2-Carboxyethyl)-1,1-dimethyl-1H-benzo[e]indol-3-ium-2-yl)hepta-2,4,6-trien-1-ylidene)-1,1-dimethyl-1,2-dihydro-3H-benzo[e]indol-3-yl)propanoate
  • lipo Cy7.5(diPrAcid)
  • lipo Cypate
CAS:
95837-47-1
MF:
C41H40N2O4
MW:
624.78
Mol File:
95837-47-1.mol
More
Less

cypate Chemical Properties

InChIKey
WKEOTLJATWJLPG-UHFFFAOYSA-N
SMILES
CC1(C(=[N+](CCC(=O)[O-])C2=CC=C3C=CC=CC3=C12)C=CC=CC=CC=C1C(C2=C3C=CC=CC3=CC=C2N1CCC(=O)O)(C)C)C
More
Less

cypate Usage And Synthesis

Uses

Cypate, a cyanine dye, is a near infrared (NIR)?fluorescent?probe for in vivo tumor imaging[1][2].

in vivo

Cypate (10 nmol; IV; every 24 hours for 6 days) causes the liver to have the highest accumulation[1].
The fluorescence signal of Cypate (5 mg/kg; IV) in the tumor of mice (Balb/c mice with 4T1 cells) is weak and quickly decayed, possibly due to fast elimination of free cypate from body. Stronger fluorescence in liver and kidney is observed in free cypate group. The Cypate fluorescence signal is assessed using an IVIS Lumina imaging system (Ex-745 nm; Em-800 nm)[2].

Animal Model:Foxn1nu/Foxn1nu nude 2.5-month-old female mice with breast cancer cells (MDA-MB-231 Luc2)[1]
Dosage:10 nmol in 100?μL PBS
Administration:IV; every 24 hours for 6 days
Result:The accumulation alone in the tumor was negligible for 24 hours after the injection.
The liver had the highest accumulation at all time points.

References

[1] Mona Doshi, et al. ?Cypate and Cypate-Glucosamine as Near-Infrared Fluorescent Probes for In Vivo Tumor Imaging. Mol Pharmacol. 2019 May;95(5):475-489. DOI:10.1124/mol.118.114199
[2] Yuanyuan Li, et al. Light-Decomposable Polymeric Micelles with Hypoxia-Enhanced Phototherapeutic Efficacy for Combating Metastatic Breast Cancer. Pharmaceutics. 2022 Jan 21;14(2):253. DOI:10.3390/pharmaceutics14020253

cypateSupplier

Xi'an Kaixin Biotechnology Co., Ltd Gold
Tel
029-68881181 13619217766
Email
3495811982@qq.com
Suzhou Su Taike Biological Reagent Co., Ltd. Gold
Tel
0512-0512-65884469 18352410772
Email
seetech@126.com
Jinan Kewei Biotechnology Co., LTD Gold
Tel
15315592897
Email
xmxingbjlg@163.com
Okeanos Tech Co,. Ltd.
Tel
010-62651721 18610486005
Email
minghui.yu@okeanos.com.cn
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com